海外の治験の状況「1」での検索結果
2290件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)
- FTLD;Progressive Supranuclear Palsy (PSP);Frontotemporal Dementia (FTD);Corticobasal Degeneration (CBD);PPA Syndrome;Behavioral Variant Frontotemporal Dementia (bvFTD);Semantic Variant Primary Progressive Aphasia (svPPA);Nonfluent Variant Primary Progressive Aphasia (nfvPPA);FTD With Amyotrophic Lateral Sclerosis (FTD/ALS);Amyotrophic Lateral Sclerosis (ALS);Oligosymptomatic PSP (oPSP);Corticobasal Syndrome (CBS)
- Canada, United States
- 2015-02-11
Recruiting
- A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)
- Hepatosplenic T-Cell Lymphoma
- United States
- 2013-02-01
Recruiting
- Evaluating the Relationship Between Tau PET Imaging and CSF Biomarkers of AD (Alzheimer Disease) in Humans
- Alzheimer Disease
- United States
- 2016-10-31
Recruiting
- Open-Label, Multicenter, Phase 1/2 Study of Tazemetostat (EZH2 Histone Methyl Transferase [HMT] Inhibitor) as a Single Agent in Subjects With Adv. Solid Tumors or With B-cell Lymphomas and Tazemetostat in Combination With Prednisolone in Subjects With DLBCL
- B-cell Lymphomas (Phase 1);Advanced Solid Tumors (Phase 1);Diffuse Large B-cell Lymphoma (Phase 2);Follicular Lymphoma (Phase 2);Transformed Follicular Lymphoma;Primary Mediastinal Large B-Cell Lymphoma
- Australia, Canada, France, Germany, Italy, Poland, Taiwan, Ukraine, United Kingdom, United States
- 2013-06-21
Recruiting
- A Randomized Controlled Trial of Doxazosin for Nightmares, Sleep Disturbance, and Non-Nightmare Clinical Symptoms in PTSD
- Stress Disorders, Post-Traumatic
- United States
- 2017-11-06
Recruiting
- Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
- Epstein-Barr Virus Infections;Lymphoma;Lymphoproliferative Disorder;Disorders, Lymphoproliferative
- United States
- 2017-08-22
Recruiting
- Gemtuzumab Ozogamicin With G-CSF, Cladribine, Cytarabine and Mitoxantrone in Treating Participants With Previously Untreated Acute Myeloid Leukemia or High-Grade Myeloid Neoplasm
- Acute Myeloid Leukemia;High-Grade Myeloid Neoplasm
- United States
- 2018-05-09
Recruiting
- Safety Study of Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Traumatic Brain Injury: Dosing Tier 1
- Traumatic Brain Injury
- Canada
- 2010-11-10
Recruiting
- A Safety, Tolerability, and Pharmacokinetics Study of a Single Intravenous Injection of Recombinant Coagulation Factor VIII Fc - Von Willebrand Factor - XTEN Fusion Protein (rFVIIIFc-VWF-XTEN) (BIVV001) in Previously Treated Adults With Severe Hemophilia A (EXTEN-A)
- Hemophilia A
- Japan, United States
- 2017-06-29
Recruiting
- Tabelecleucel for Allogeneic Hematopoietic Cell Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab
- Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD);Stem Cell Transplant Complications;Lymphoproliferative Disorders
- Australia, United States
- 2017-12-29
Recruiting
- Tabelecleucel for Solid Organ Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy
- Epstein-Barr Virus-Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD);Solid Organ Transplant Complications;Lymphoproliferative Disorders
- Australia, United States
- 2017-12-29
Recruiting
- Pfizer Immunotherapy Combinations for Acute Myeloid Leukemia (AML) Multi-Arm Study 1
- Acute Myeloid Leukemia
- United States
- 2017-12-28
Recruiting
- A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Belgium, France, Germany, Israel, Italy, Netherlands, Spain, Sweden, United Kingdom, United States
- 2017-12-20
Recruiting
- Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
- Spectrin-associated Autosomal Recessive Cerebellar Ataxia;Spasticity-ataxia-gait Anomalies Syndrome;Spastic Ataxia With Congenital Miosis;Spastic Ataxia - Corneal Dystrophy;Spastic Ataxia;Rare Hereditary Ataxia;Rare Ataxia;Recessive Mitochondrial Ataxia Syndrome;Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;Posterior Column Ataxia - Retinitis Pigmentosa;Post-Stroke Ataxia;Post-Head Injury Ataxia;Post Vaccination Ataxia;Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract;Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus;Non-progressive Cerebellar Ataxia With Intellectual Disability;Non-hereditary Degenerative Ataxia;Paroxysmal Dystonic Choreathetosis With Episodic Ataxia and Spasticity;Olivopontocerebellar Atrophy - Deafness;NARP Syndrome;Myoclonus - Cerebellar Ataxia - Deafness;Multiple System Atrophy, Parkinsonian Type;Multiple System Atrophy, Cerebellar Type;Multiple System Atrophy;Maternally-inherited Leigh Syndrome;Machado-Joseph Disease Type 3;Machado-Joseph Disease Type 2;Machado-Joseph Disease Type 1;Lethal Ataxia With Deafness and Optic Atrophy;Leigh Syndrome;Leukoencephalopathy With Mild Cerebellar Ataxia and White Matter Edema;Leukoencephalopathy - Ataxia - Hypodontia - Hypomyelination;Leigh Syndrome With Nephrotic Syndrome;Leigh Syndrome With Leukodystrophy;Leigh Syndrome With Cardiomyopathy;Late-onset Ataxia With Dementia;Intellectual Disability-hyperkinetic Movement-truncal Ataxia Syndrome;Infection or Post Infection Ataxia;Infantile-onset Autosomal Recessive Nonprogressive Cerebellar Ataxia;Infantile Onset Spinocerebellar Ataxia;GAD Ataxia;Hereditary Episodic Ataxia;Gliadin/Gluten Ataxia;Friedreich Ataxia;Fragile X-associated Tremor/Ataxia Syndrome;Familial Paroxysmal Ataxia;Exposure to Medications Ataxia;Episodic Ataxia With Slurred Speech;Episodic Ataxia Unknown Type;Episodic Ataxia Type 7;Episodic Ataxia Type 6;Episodic Ataxia Type 5;Episodic Ataxia Type 4;Episodic Ataxia Type 3;Episodic Ataxia Type 1;Epilepsy and/or Ataxia With Myoclonus as Major Feature;Early-onset Spastic Ataxia-neuropathy Syndrome;Early-onset Progressive Neurodegeneration - Blindness - Ataxia - Spasticity;Early-onset Cerebellar Ataxia With Retained Tendon Reflexes;Early-onset Ataxia With Dementia;Childhood-onset Autosomal Recessive Slowly Progressive Spinocerebellar Ataxia;Dilated Cardiomyopathy With Ataxia;Cataract - Ataxia - Deafness;Cerebellar Ataxia, Cayman Type;Cerebellar Ataxia With Peripheral Neuropathy;Cerebellar Ataxia - Hypogonadism;Cerebellar Ataxia - Ectodermal Dysplasia;Cerebellar Ataxia - Areflexia - Pes Cavus - Optic Atrophy - Sensorineural Hearing Loss;Brain Tumor Ataxia;Brachydactyly - Nystagmus - Cerebellar Ataxia;Benign Paroxysmal Tonic Upgaze of Childhood With Ataxia;Autosomal Recessive Syndromic Cerebellar Ataxia;Autosomal Recessive Spastic Ataxia With Leukoencephalopathy;Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay;Autosomal Recessive Spastic Ataxia - Optic Atrophy - Dysarthria;Autosomal Recessive Spastic Ataxia;Autosomal Recessive Metabolic Cerebellar Ataxia;Autosomal Dominant Spinocerebellar Ataxia Due to Repeat Expansions That do Not Encode Polyglutamine;Autosomal Recessive Ataxia, Beauce Type;Autosomal Recessive Ataxia Due to Ubiquinone Deficiency;Autosomal Recessive Ataxia Due to PEX10 Deficiency;Autosomal Recessive Degenerative and Progressive Cerebellar Ataxia;Autosomal Recessive Congenital Cerebellar Ataxia Due to MGLUR1 Deficiency;Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency;Autosomal Recessive Congenital Cerebellar Ataxia;Autosomal Recessive Cerebellar Ataxia-pyramidal Signs-nystagmus-oculomotor Apraxia Syndrome;Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to WWOX Deficiency;Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to TUD Deficiency;Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to KIAA0226 Deficiency;Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome;Autosomal Recessive Cerebellar Ataxia With Late-onset Spasticity;Autosomal Recessive Cerebellar Ataxia Due to STUB1 Deficiency;Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect;Autosomal Recessive Cerebellar Ataxia - Saccadic Intrusion;Autosomal Recessive Cerebellar Ataxia - Psychomotor Retardation;Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness;Autosomal Recessive Cerebellar Ataxia;Autosomal Dominant Spinocerebellar Ataxia Due to a Polyglutamine Anomaly;Autosomal Dominant Spinocerebellar Ataxia Due to a Point Mutation;Autosomal Dominant Spinocerebellar Ataxia Due to a Channelopathy;Autosomal Dominant Spastic Ataxia Type 1;Autosomal Dominant Spastic Ataxia;Autosomal Dominant Optic Atrophy;Ataxia-telangiectasia Variant;Ataxia-telangiectasia;Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy;Autosomal Dominant Cerebellar Ataxia Type 4;Autosomal Dominant Cerebellar Ataxia Type 3;Autosomal Dominant Cerebellar Ataxia Type 2;Autosomal Dominant Cerebellar Ataxia Type 1;Autosomal Dominant Cerebellar Ataxia;Ataxia-telangiectasia-like Disorder;Ataxia-intellectual Disability-oculomotor Apraxia-cerebellar Cysts Syndrome;Ataxia-deafness-intellectual Disability Syndrome;Ataxia With Vitamin E Deficiency;Ataxia With Dementia;Ataxia Neuropathy Spectrum;Ataxia - Tapetoretinal Degeneration;Ataxia - Photosensitivity - Short Stature;Ataxia - Pancytopenia;Ataxia - Oculomotor Apraxia Type 1;Ataxia - Hypogonadism - Choroidal Dystrophy;Ataxia - Other;Ataxia - Genetic Diagnosis - Unknown;Acquired Ataxia;Adult-onset Autosomal Recessive Cerebellar Ataxia;Alcohol Related Ataxia;Multiple Endocrine Neoplasia;Multiple Endocrine Neoplasia Type II;Multiple Endocrine Neoplasia Type 1;Multiple Endocrine Neoplasia Type 2;Multiple Endocrine Neoplasia, Type IV;Multiple Endocrine Neoplasia, Type 3;Multiple Endocrine Neoplasia (MEN) Syndrome;Multiple Endocrine Neoplasia Type 2B;Multiple Endocrine Neoplasia Type 2A;Atypical Hemolytic Uremic Syndrome;Atypical HUS;Wiedemann-Steiner Syndrome;Breast Implant-Associated Anaplastic Large Cell Lymphoma;Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA);Hemophagocytic Lymphohistiocytosis;Behcet's Disease;Spinocerebellar Ataxia Type 17;Spinocerebellar Ataxia Type 16;Spinocerebellar Ataxia Type 15/16;Spinocerebellar Ataxia Type 14;Spinocerebellar Ataxia Type 13;Spinocerebellar Ataxia Type 12;Spinocerebellar Ataxia Type 11;Spinocerebellar Ataxia Type 10;Spinocerebellar Ataxia Type 1 With Axonal Neuropathy;Spinocerebellar Ataxia Type 1;Spinocerebellar Ataxia - Unknown;Spinocerebellar Ataxia - Dysmorphism;Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;Alagille Syndrome;Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia (IBMPFD);Lowe Syndrome;Pitt Hopkins Syndrome;1p36 Deletion Syndrome;Jansen Type Metaphyseal Chondrodysplasia;Cockayne Syndrome;Chronic Recurrent Multifocal Osteomyelitis;CRMO;Malan Syndrome;Hereditary Sensory and Autonomic Neuropathy Type Ie;Rare Disorders;Undiagnosed Disorders;Disorders of Unknown Prevalence;Cornelia De Lange Syndrome;Prenatal Benign Hypophosphatasia;Perinatal Lethal Hypophosphatasia;Odontohypophosphatasia;Adult Hypophosphatasia;Childhood-onset Hypophosphatasia;Infantile Hypophosphatasia;Hypophosphatasia;Kabuki Syndrome;Bohring-Opitz Syndrome;Narcolepsy Without Cataplexy;Narcolepsy-cataplexy;Hypersomnolence Disorder;Idiopathic Hypersomnia Without Long Sleep Time;Idiopathic Hypersomnia With Long Sleep Time;Idiopathic Hypersomnia;Kleine-Levin Syndrome;Kawasaki Disease;Leiomyosarcoma;Leiomyosarcoma of the Corpus Uteri;Leiomyosarcoma of the Cervix Uteri;Leiomyosarcoma of Small Intestine;Acquired Myasthenia Gravis;Addison Disease;Hyperacusis (Hyperacousis);Juvenile Myasthenia Gravis;Transient Neonatal Myasthenia Gravis;Williams Syndrome;Lyme Disease;Myasthenia Gravis;Marinesco Sjogren Syndrome(Marinesco-Sjogren Syndrome);Isolated Klippel-Feil Syndrome;Frasier Syndrome;Denys-Drash Syndrome;Beckwith-Wiedemann Syndrome;Emanuel Syndrome;Isolated Aniridia;Beckwith-Wiedemann Syndrome Due to Paternal Uniparental Disomy of Chromosome 11;Beckwith-Wiedemann Syndrome Due to Imprinting Defect of 11p15;Beckwith-Wiedemann Syndrome Due to 11p15 Translocation/Inversion;Beckwith-Wiedemann Syndrome Due to 11p15 Microduplication;Beckwith-Wiedemann Syndrome Due to 11p15 Microdeletion;Axenfeld-Rieger Syndrome;Aniridia-intellectual Disability Syndrome;Aniridia - Renal Agenesis - Psychomotor Retardation;Aniridia - Ptosis - Intellectual Disability - Familial Obesity;Aniridia - Cerebellar Ataxia - Intellectual Disability;Aniridia - Absent Patella;Aniridia;Peters Anomaly - Cataract;Peters Anomaly;Potocki-Shaffer Syndrome;Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11;Silver-Russell Syndrome Due to Imprinting Defect of 11p15;Silver-Russell Syndrome Due to 11p15 Microduplication;Syndromic Aniridia;WAGR Syndrome;Wolf-Hirschhorn Syndrome;4p16.3 Microduplication Syndrome;4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome;Autosomal Recessive Stickler Syndrome;Stickler Syndrome Type 2;Stickler Syndrome Type 1;Stickler Syndrome;Mucolipidosis Type 4;X-linked Spinocerebellar Ataxia Type 4;X-linked Spinocerebellar Ataxia Type 3;X-linked Intellectual Disability - Ataxia - Apraxia;X-linked Progressive Cerebellar Ataxia;X-linked Non Progressive Cerebellar Ataxia;X-linked Cerebellar Ataxia;Vitamin B12 Deficiency Ataxia;Toxic Exposure Ataxia;Unclassified Autosomal Dominant Spinocerebellar Ataxia;Thyroid Antibody Ataxia;Sporadic Adult-onset Ataxia of Unknown Etiology;Spinocerebellar Ataxia With Oculomotor Anomaly;Spinocerebellar Ataxia With Epilepsy;Spinocerebellar Ataxia With Axonal Neuropathy Type 2;Spinocerebellar Ataxia Type 8;Spinocerebellar Ataxia Type 7;Spinocerebellar Ataxia Type 6;Spinocerebellar Ataxia Type 5;Spinocerebellar Ataxia Type 4;Spinocerebellar Ataxia Type 37;Spinocerebellar Ataxia Type 36;Spinocerebellar Ataxia Type 35;Spinocerebellar Ataxia Type 34;Spinocerebellar Ataxia Type 32;Spinocerebellar Ataxia Type 31;Spinocerebellar Ataxia Type 30;Spinocerebellar Ataxia Type 3;Spinocerebellar Ataxia Type 29;Spinocerebellar Ataxia Type 28;Spinocerebellar Ataxia Type 27;Spinocerebellar Ataxia Type 26;Spinocerebellar Ataxia Type 25;Spinocerebellar Ataxia Type 23;Spinocerebellar Ataxia Type 22;Spinocerebellar Ataxia Type 21;Spinocerebellar Ataxia Type 20;Spinocerebellar Ataxia Type 2;Spinocerebellar Ataxia Type 19/22;Spinocerebellar Ataxia Type 18
- Australia, United States
- 2013-02-13
Recruiting
- The Natural History of Familial Dysautonomia
- Familial Dysautonomia (Riley-Day Syndrome);Hereditary Sensory and Autonomic Neuropathies;Hereditary Sensory and Autonomic Neuropathy 3
- Israel, United States
- 2019-04-04
Recruiting
- Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
- SCAD;Addison Disease;Ankylosing Spondylitis;Antiphospholipid Antibody Syndrome;Celiac Disease;Crohn Disease;Dermatomyositis;Polymyositis;Guillain-Barre Syndrome;Hepatitis, Autoimmune;Graves Disease;Hashimoto Thyroiditis;Multiple Sclerosis;Myasthenia Gravis;Pernicious Anemia;Polymyalgia Rheumatica;Primary Biliary Cirrhosis;Psoriasis;Rheumatoid Arthritis;Systemic Sclerosis;Sjögren Syndrome;Systemic Lupus Erythematosus;Takayasu Arteritis;Type 1 Diabetes Mellitus;Ulcerative Colitis;Uveitis;Vasculitis;Vitiligo;Raynaud
- United States
- 2019-04-01
Recruiting
- Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475
- ALK Gene Mutation;BRAF Gene Mutation;EGFR Gene Mutation;Head and Neck Squamous Cell Carcinoma;Metastatic Head and Neck Carcinoma;Recurrent Head and Neck Carcinoma;Recurrent Non-Small Cell Lung Carcinoma;ROS1 Gene Mutation;Stage III Non-Small Cell Lung Cancer;Stage IIIA Non-Small Cell Lung Cancer;Stage IIIB Non-Small Cell Lung Cancer;Stage IV Non-Small Cell Lung Cancer;ALK Gene Mutation;BRAF Gene Mutation;EGFR Gene Mutation;Head and Neck Squamous Cell Carcinoma;Metastatic Head and Neck Carcinoma;Recurrent Head and Neck Carcinoma;Recurrent Non-Small Cell Lung Carcinoma;ROS1 Gene Mutation;Stage III Non-Small Cell Lung Cancer;Stage IIIA Non-Small Cell Lung Cancer;Stage IIIB Non-Small Cell Lung Cancer;Stage IV Non-Small Cell Lung Cancer;ALK Gene Mutation;BRAF Gene Mutation;EGFR Gene Mutation;Head and Neck Squamous Cell Carcinoma;Metastatic Head and Neck Carcinoma;Recurrent Head and Neck Carcinoma;Recurrent Non-Small Cell Lung Carcinoma;ROS1 Gene Mutation;Stage III Non-Small Cell Lung Cancer;Stage IIIA Non-Small Cell Lung Cancer;Stage IIIB Non-Small Cell Lung Cancer;Stage IV Non-Small Cell Lung Cancer
- United States
- 2017-02-08
Recruiting
- Molecular and Genetic Studies of Congenital Myopathies
- Central Core Disease;Centronuclear Myopathy;Congenital Fiber Type Disproportion;Multiminicore Disease;Myotubular Myopathy;Nemaline Myopathy;Rigid Spine Muscular Dystrophy;Undefined Congenital Myopathy;Central Core Disease;Centronuclear Myopathy;Congenital Fiber Type Disproportion;Multiminicore Disease;Myotubular Myopathy;Nemaline Myopathy;Rigid Spine Muscular Dystrophy;Undefined Congenital Myopathy;Central Core Disease;Centronuclear Myopathy;Congenital Fiber Type Disproportion;Multiminicore Disease;Myotubular Myopathy;Nemaline Myopathy;Rigid Spine Muscular Dystrophy;Undefined Congenital Myopathy
- United States
- 2006-01-05
Recruiting
- T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts
- Acute Lymphoblastic Leukemia;Non Hodgkins Lymphoma;Myelodysplastic Syndrome;Acute Myeloid Leukemia;Chronic Myelogenous Leukemia;Hemophagocytic Lymphohistiocytosis (HLH);Familial Hemophagocytic Lymphohistiocytosis (FLH);Viral-associated Hemophagocytic Syndrome (VAHS);X-linked Lymphoproliferative Disease (XLP)
- United States
- 2005-09-21
Recruiting
- MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer
- Estrogen Receptor-negative Breast Cancer;Progesterone Receptor-negative Breast Cancer;Stage IA Breast Cancer;Stage IB Breast Cancer;Stage II Breast Cancer;Triple-negative Breast Cancer
- United States
- 2013-02-24
